Merck-Wellcome Joint Venture Ties Up With MEND To Focus On A Heat-Stable Rotavirus Vaccine For Developing Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
On completion of Phase II efficacy studies, and once the prototype is in place, the JV, Hilleman Labs, will look at partnering for the manufacturing and commercialization phase.